Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Regorafenib industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Drug International
Bayer Pharmaceuticals
Beacon Pharmaceuticals
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Bottled Packaging
Film Coated Packaging
Application:
Metastatic Colorectal Cancer
Advanced Gastrointestinal Stromal Tumours
Advanced Hepatocellular Carcinoma
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Regorafenib Industry Overview
-
1.1.1 Regorafenib Market Scope and Market Segments
-
1.1.2 Regorafenib Industry Characteristics
-
1.1.3 Global and China Regorafenib Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Regorafenib Production Value and Growth Rate (2017-2028)
-
1.2 Global Regorafenib Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Bottled Packaging
-
1.2.2 Film Coated Packaging
-
1.3 Global Regorafenib Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Metastatic Colorectal Cancer
-
1.3.2 Advanced Gastrointestinal Stromal Tumours
-
1.3.3 Advanced Hepatocellular Carcinoma
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Regorafenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Regorafenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Regorafenib Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Regorafenib Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Regorafenib Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Regorafenib Industry Porter's Five Forces Model Analysis
-
2.2.3 Regorafenib Industry PEST Analysis
-
2.3 Regorafenib Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Regorafenib Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Regorafenib Industry
Chapter 3 Global and China Regorafenib Market, by Manufacturer
-
3.1 Global and China Regorafenib Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Regorafenib Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Regorafenib Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Regorafenib Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Regorafenib Market Top 3 Players
Chapter 4 Global and China Regorafenib Market, by Type (2017-2028)
-
4.1 Regorafenib Market Trend, by Type
-
4.2 Global Regorafenib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Regorafenib Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Regorafenib Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Regorafenib Price Trend, by Type (2017-2028)
-
4.3 China Regorafenib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Regorafenib Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Regorafenib Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Regorafenib Price Trend, by Type (2017-2028)
Chapter 5 Global and China Regorafenib Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Regorafenib Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Regorafenib Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Regorafenib Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Regorafenib Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Regorafenib Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Regorafenib Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Regorafenib Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Regorafenib Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Regorafenib Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Regorafenib Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Regorafenib Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Regorafenib Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Regorafenib Market Analysis
-
7.1 North America Regorafenib Market, by Type
-
7.2 North America Regorafenib Market, by Application
-
7.3 North America Regorafenib Market Analysis and Forecast, by Country
-
7.3.1 United States Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Regorafenib Market Analysis
-
8.1 Europe Regorafenib Market, by Type
-
8.2 Europe Regorafenib Market, by Application
-
8.3 Europe Regorafenib Market Analysis and Forecast, by Country
-
8.3.1 Germany Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Regorafenib Market Analysis
-
9.1 APAC Regorafenib Market, by Type
-
9.2 APAC Regorafenib Market, by Application
-
9.3 APAC Regorafenib Market Analysis and Forecast, by Country
-
9.3.1 China Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Regorafenib Market Analysis
-
10.1 Latin America, Middle East and Africa Regorafenib Market, by Type
-
10.2 Latin America, Middle East and Africa Regorafenib Market, by Application
-
10.3 Latin America, Middle East and Africa Regorafenib Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Regorafenib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Regorafenib Company Profiles
-
11.1 Drug International
-
11.1.1 Drug International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Drug International Regorafenib Product Profiles, Application and Specification
-
11.1.3 Drug International Regorafenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Bayer Pharmaceuticals
-
11.2.1 Bayer Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Bayer Pharmaceuticals Regorafenib Product Profiles, Application and Specification
-
11.2.3 Bayer Pharmaceuticals Regorafenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Beacon Pharmaceuticals
-
11.3.1 Beacon Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Beacon Pharmaceuticals Regorafenib Product Profiles, Application and Specification
-
11.3.3 Beacon Pharmaceuticals Regorafenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Regorafenib Industry Investment Prospect and Risk Assessment
-
12.1 Regorafenib Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Regorafenib Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure China Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Global Regorafenib Production Value and Growth Rate (2017-2028)
-
Figure China Regorafenib Production Value and Growth Rate (2017-2028)
-
Figure Global Regorafenib Market Size and Growth Rate of Bottled Packaging (2017-2028)
-
Figure Global Regorafenib Market Size and Growth Rate of Film Coated Packaging (2017-2028)
-
Figure Global Regorafenib Market Size and Growth Rate of Metastatic Colorectal Cancer (2017-2028)
-
Figure Global Regorafenib Market Size and Growth Rate of Advanced Gastrointestinal Stromal Tumours (2017-2028)
-
Figure Global Regorafenib Market Size and Growth Rate of Advanced Hepatocellular Carcinoma (2017-2028)
-
Figure Global Regorafenib Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Regorafenib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Regorafenib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Regorafenib Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Regorafenib Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Regorafenib Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Regorafenib Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Regorafenib Market Share, by Manufacturer in 2021
-
Figure Global and China Regorafenib Market Share, by Manufacturer in 2022
-
Table Global Regorafenib Sales Volume, by Type (2017-2028)
-
Table Global Regorafenib Sales Volume Share, by Type (2017-2028)
-
Figure Global Regorafenib Sales Volume Share, by Type (2017-2028)
-
Table Global Regorafenib Sales Value, by Type (2017-2028)
-
Table Global Regorafenib Sales Value Share, by Type (2017-2028)
-
Figure Global Regorafenib Price Trend, by Type (2017-2028)
-
Table China Regorafenib Sales Volume, by Type (2017-2028)
-
Table China Regorafenib Sales Volume Share, by Type (2017-2028)
-
Figure China Regorafenib Sales Volume Share, by Type (2017-2028)
-
Table China Regorafenib Sales Value, by Type (2017-2028)
-
Table China Regorafenib Sales Value Share, by Type (2017-2028)
-
Figure China Regorafenib Price Trend, by Type (2017-2028)
-
Table Global Regorafenib Sales Volume, by Application (2017-2028)
-
Table Global Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure Global Regorafenib Sales Volume Share, by Application (2017-2028)
-
Table Global Regorafenib Sales Value, by Application (2017-2028)
-
Table Global Regorafenib Sales Value Share, by Application (2017-2028)
-
Figure Global Regorafenib Sales Value Share, by Application (2017-2028)
-
Table China Regorafenib Sales Volume, by Application (2017-2028)
-
Table China Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure China Regorafenib Sales Volume Share, by Application (2017-2028)
-
Table China Regorafenib Sales Value, by Application (2017-2028)
-
Table China Regorafenib Sales Value Share, by Application (2017-2028)
-
Figure China Regorafenib Sales Value Share, by Application (2017-2028)
-
Figure China Regorafenib Production, Import, Consumption and Export (2017-2022)
-
Figure North America Regorafenib Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Regorafenib Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Regorafenib Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Regorafenib Production, Import, Consumption and Export (2017-2022)
-
Table North America Regorafenib Sales Volume, by Type (2017-2028)
-
Table North America Regorafenib Sales Volume Share, by Type (2017-2028)
-
Figure North America Regorafenib Sales Volume Share, by Type (2017-2028)
-
Table North America Regorafenib Sales Volume, by Application (2017-2028)
-
Table North America Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure North America Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure United States Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure United States Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Canada Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Regorafenib Sales Value and Growth Rate (2017-2028)
-
Table Europe Regorafenib Sales Volume, by Type (2017-2028)
-
Table Europe Regorafenib Sales Volume Share, by Type (2017-2028)
-
Figure Europe Regorafenib Sales Volume Share, by Type (2017-2028)
-
Table Europe Regorafenib Sales Volume, by Application (2017-2028)
-
Table Europe Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure Europe Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure Germany Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure UK Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure UK Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure France Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure France Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Italy Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Spain Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Poland Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Russia Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Regorafenib Sales Value and Growth Rate (2017-2028)
-
Table APAC Regorafenib Sales Volume, by Type (2017-2028)
-
Table APAC Regorafenib Sales Volume Share, by Type (2017-2028)
-
Figure APAC Regorafenib Sales Volume Share, by Type (2017-2028)
-
Table APAC Regorafenib Sales Volume, by Application (2017-2028)
-
Table APAC Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure APAC Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure China Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure China Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Japan Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure India Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure India Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Regorafenib Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Regorafenib Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Regorafenib Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Regorafenib Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Regorafenib Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Regorafenib Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Regorafenib Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Regorafenib Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Regorafenib Sales Value and Growth Rate (2017-2028)
-
Table Drug International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Drug International Product Profiles, Application and Specification
-
Table Drug International Regorafenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Pharmaceuticals Product Profiles, Application and Specification
-
Table Bayer Pharmaceuticals Regorafenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Beacon Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beacon Pharmaceuticals Product Profiles, Application and Specification
-
Table Beacon Pharmaceuticals Regorafenib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
